Skip To Main Content
David Cella on Muck Rack

David Cella

As seen in: Color Research & Application, Nature, Wiley Online Library, PLOS ONE, Taylor & Francis Online, Biomed Central (BMC), JAMA (The Journal of the American Medical Association), JAMA Oncology, JAMA: Journal of the American Medical Association, The Lancet and
common sence is like deodorent... the people who need it the most, never seem to use it We Aidens are so popular, parents be stealing our name
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with David

Contact David, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Stakeholder perspectives on potential open-label bias in patient-reported outcome results from cancer clinical trials: evidence from the IMPROvE project

|
By Fabio Efficace, Neil K. Aaronson, David Cella, Daniela Krepper, Francesco Sparano, Gary Collins, Johannes M Giesinger, Rajshekhar Chakraborty, Massimo Di Maio, Amélie Anota
| Value in Health Journal Verified
Affiliations & Notes 1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy 2University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria 3Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands 4Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA 5Department of Applied Health Sciences, School of...
Open in Who Shared Issue with article?

Symptoms and subtypes of patients with lower urinary tract dysfunction — insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network

|
By Claire Yang, Ziya Kirkali, Anne P. Cameron, H. Henry Lai, David Cella, Victor P. Andreev, Karl Kreder, Catherine S. Bradley, Brian Helfand, J. Quentin Clemens, Cindy L. Amundsen, Abigail Smith, Kevin Weinfurt
| Nature Verified
Abstract Lower urinary tract dysfunction presents with a wide range of bothersome urinary symptoms, which are common in both men and women, with incidence and prevalence increasing with age. Individuals with lower urinary tract symptoms (LUTS) suffer from the chronicity of their symptoms, have a reduced quality of life, and experience high morbidity with associated medical conditions. Various treatment options exist, but many patients do not find satisfactory or lasting relief.
Open in Who Shared Issue with article?

Patient-Reported Outcome Measures in Clinical Trials: An Analysis of Trends from 2008-2023

|
By Maja Kuharic, Justin Yu, Mrinmayee Joshi, Jonathan Nazari, Fatih Zecic, David Cella, A.Simon Pickard
| Value in Health Journal Verified
Precis: PRO measure use in interventional trials doubled from 2008-2023, with EQ-5D becoming the leading generic measure and PROMIS showing fastest growth. Authorship Contribution: All authors certify that they meet the ICMJE criteria for authorship. Funding Source: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Open in Who Shared Issue with article?
See all 38 licensed articles (40 Total)